Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.
Banerjee S, Ghosh J, Sen S, Guha R, Dhar R, Ghosh M, Datta S, Raychaudhury B, Naskar K, Haldar AK, Lal CS, Pandey K, Das VN, Das P, Roy S.
Banerjee S, et al. Among authors: das vn, das p.
Infect Immun. 2009 Jun;77(6):2330-42. doi: 10.1128/IAI.00057-09. Epub 2009 Mar 16.
Infect Immun. 2009.
PMID: 19289510
Free PMC article.